SEGMENT INFORMATION

9 Months Ended

Sep. 30, 2012

SEGMENT INFORMATION

SEGMENT INFORMATION

10. SEGMENT INFORMATION

        The Company operates in one reportable segment—the research, development and sale of medical devices to diagnose disease. The Company's chief operating decision maker reviews financial information for the Company as a whole for purposes of allocating resources and evaluating financial performance. Substantially all long-lived assets of the Company are in the United States. Sales for each significant geographical area are as follows:

	Three months Ended September 30,										Nine months Ended September 30,
	2012					2011					2012					2011
	Product Sales		%			Product Sales		%			Product Sales		%			Product Sales		%
	(in thousands)					(in thousands)					(in thousands)					(in thousands)
North America	$	64		16	%	$	42		6	%	$	297		23	%	$	282		13	%
Europe		20		5	%		515		66	%		344		26	%		1,197		54	%
Asia		287		69	%		220		28	%		465		36	%		426		19	%
Latin America		41		10	%		—		—			196		15	%		219		10	%
Australia		1		—			1		—			1		—			90		4	%
Total	$	413		100	%	$	778		100	%	$	1,303		100	%	$	2,214		100	%